vTv Therapeutics Inc (NASDAQ: VTVT) stock closed at $19.00 on 6/5/24 after a major decline of -11.6%. However, trading volume in this decline was exceptionally low at 37% of normal. The stock has been exceptionally strong relative to the market over the last nine months but has declined -23.0% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, VTVT is expected to continue to be a major Value Eraser.
vTv Therapeutics is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment